Journal article
Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT
Abstract
BACKGROUND: There has been a steady increase in the number of primary care patients receiving long-term maintenance antidepressant treatment, despite limited evidence of a benefit of this treatment beyond 8 months.
OBJECTIVE: The ANTidepressants to prevent reLapse in dEpRession (ANTLER) trial investigated the clinical effectiveness and cost-effectiveness of antidepressant medication in preventing relapse in UK primary care.
Authors
Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M
Journal
Health Technology Assessment, Vol. 25, No. 69, pp. 1–62
Publisher
National Institute for Health and Care Research
Publication Date
November 2021
DOI
10.3310/hta25690
ISSN
1366-5278